The Efficacy of Palmitoylethanolamide (Levagen+) on the Incidence and Symptoms of Upper Respiratory Tract Infection-A Double Blind, Randomised, Placebo-Controlled Trial.
Amanda RaoRachael SkinnerDavid BriskeyPublished in: Nutrients (2023)
The results of this study show Levagen+ to be safe and effective in reducing the incidence and symptoms associated with URTIs.